Home / Inspections / 1064728

FDA Inspection 1064728 — University Of Texas MD Anderson Cancer Center

University Of Texas MD Anderson Cancer Center — FEI 1670014

The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on Aug 27, 2018 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 27, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Facility

Other inspections at this facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.